Porcine Coronary Artery Smooth Muscle Cells: PCASMC
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) are primary smooth muscle cells isolated from the porcine coronary circulation.
Description
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) are primary smooth muscle cells isolated from the porcine coronary circulation, serving as an established experimental model for investigating vascular smooth muscle biology, arterial remodeling, and cardiovascular disease mechanisms.
In vivo, vascular smooth muscle cells populate the tunica media of large vessels such as the aorta and coronary arteries (including the right coronary artery), where they regulate vascular tone, structural stability, and hemodynamic responses. In experimental research, PCASMC — alongside comparative models utilizing animal primary cells, porcine primary cells, and related stem cell or mouse systems — have been used to study key molecular pathways driving cellular proliferation and pathological remodeling. For instance, studies have demonstrated that the transcription factor c-Jun plays a critical role in promoting vascular smooth muscle cell proliferation, and that the targeted inhibition of c-Jun can abrogate smooth muscle cell growth and attenuate intimal thickening following vascular injury. Beyond injury models, PCASMC are widely applied in developmental biology, tissue engineering investigations assessing the potential of nanofibrous scaffold materials, and translational research examining mechanisms relevant to atherosclerosis, atherosclerotic disease, fibrous cap formation, plaque stability, acute myocardial infarction, and coronary artery disease.
Standard characterization protocols confirm that PCASMC are positive for smooth muscle cell-specific alpha-actin expression using specific antibodies, verifying their identity and enrichment. Researchers also study aspects of SMC–endothelial crosstalk in plaque-like contexts alongside endothelial cells, examining how related pathways influence plaque progression. Furthermore, these cells serve as versatile platforms for evaluating differentially expressed genes in response to pharmacological modulators like tamoxifen, or through advanced imaging techniques. Maintaining experimental reliability requires rigorous cell culture practices, including routine screening to ensure cultures remain free from mycoplasma and other contaminants, thereby supporting accurate evaluations of gene expression, phenotype modulation, and cellular responses within complex vascular lesions.
Porcine Coronary Artery Smooth Muscle Cells (PCASMC) from Cell Applications, Inc. were used to show that:
- c-Jun plays a role in smooth muscle proliferation
- Inhibition of c-Jun abrogates smooth muscle cell growth and intimal thickening after arterial injury
- Nanofibrous scaffold material has potential for tissue engineering
Characterization: positive for smooth muscle cell specific alpha-actin expression
Details
| Tissue: | Normal healthy porcine coronary artery | |
|---|---|---|
| QC | No bacteria, yeast, fungi, mycoplasma | |
| Character | Smooth muscle specific α-actin positive | |
| Bioassay | Attach, spread, proliferate in Growth Med | |
| Cryovial | 500,000 PCASMC (2nd passage) frozen in Basal Medium w/ 10% FBS, 10% DMSO | |
| Kit | Cryovial frozen PCASMC (P350-05), Grwth Medium (P311-500), Subcltr Rgnt Kit (090K) | |
| Proliferating | Shipped in Gr Med, 3rd psg (flasks or plates) | |
| Doublings | At least 16 | |
| Applications | Laboratory research use only (RUO). Not for human, clinical, diagnostic or veterinary use. |
Resources
FAQs
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Need More Help?
Visit our comprehensive FAQ page for detailed answers to common questions.
Primary Cell FAQs